Skip to content
Preprint · OA via OpenAlex

Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy

Jussi Palomäki, Kiira Kalke, Julius Orpana, Lund Liisa, Fanny Frejborg, Henrik Paavilainen, Järveläinen Hannu, Veijo Hukkanen

UTUPub (University of Turku) · 2025

Abstract

Herpes simplex virus (HSV) has proven successful in treating human cancer. Since the approval of talimogene laherparepvec (T-VEC) in 2015, HSV has been thoroughly researched to discover novel mechanisms to combat cancer and treat other diseases. Another HSV-based drug, beremagene geperpavec (B-VEC), received approval in 2023 to treat the rare genetic disease dystrophic epidermolysis bullosa, and was also the first clinically approved HSV vector carrying an extracellular matrix (ECM)-modifying transgene. The ECM is a network of macromolecules surrounding cells, which provides support and regulates cell growth and differentiation, the disruption of which is common in cancer. The naked mole rat (NMR) has a thick ECM and a unique mutation in the hyaluronan synthase 2 (HAS2) gene, which has been linked to the high cancer resistance of the species. To study the effect of this mutation in human cancer, we have developed an attenuated, replication-competent HSV vector expressing the NMR-HAS2 gene. The viral replication, transgene expression and cytotoxic effect of the novel vector was studied in glioma cells. Our results show that an attenuated, replication-competent HSV vector expressing a foreign ECM-modifying transgene, namely HAS2, provides an effective tool to study and combat cancer in humans.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
Canonical
link ↗
Fetched
2026-11-03 MST

Cite this

APA
Palomäki, J., Kalke, K., Orpana, J., Liisa, L., Frejborg, F., Paavilainen, H., Hannu, J., &amp; Hukkanen, V. (2025). Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy. <em>UTUPub (University of Turku)</em>. https://openalex.org/W7137617239
Vancouver
Palomäki J, Kalke K, Orpana J, Liisa L, Frejborg F, Paavilainen H, et al. Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy. UTUPub (University of Turku). 2025.
BibTeX
@unpublished{jussi2025Attenu, title = {Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy}, author = {Jussi Palomäki and Kiira Kalke and Julius Orpana and Lund Liisa and Fanny Frejborg and Henrik Paavilainen and Järveläinen Hannu and Veijo Hukkanen}, journal = {UTUPub (University of Turku)}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings